Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115106) titled 'Vonoprazan-Doxycycline Dual Therapy Versus Bismuth-Containing Doxycycline-Furazolidone Quadruple Therapy as Rescue Treatment for Helicobacter pylori: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial' on Dec. 22, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: NanJing First Hospital
Condition:
helicobacter pylori infection
Intervention:
Group B:Doxycycline dual therapy
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-01
Target Sample Size: Group B:133;Group A:133;
Countries of Recruitment:
China
To know more, visit http...